- Home
- NOMA vs ANIK Comparison
NOMA vs ANIK Comparison
Compare NOMA & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NOMA | ANIK |
|---|---|---|
| Founded | 2023 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.0M | 134.8M |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | NOMA | ANIK |
|---|---|---|
| Price | $4.35 | $9.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | ★ 317.6K | 145.5K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $885,694.00 | ★ $112,806,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 30.55 |
| 52 Week Low | $3.35 | $7.87 |
| 52 Week High | $57.70 | $18.37 |
Technical Indicators
Market Signals| Indicator | NOMA | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 42.84 |
| Support Level | N/A | $9.31 |
| Resistance Level | N/A | $9.58 |
| Average True Range (ATR) | 0.00 | 0.21 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 4.59 |
Price Performance
Historical ComparisonAbout NOMA NOMADAR Corp.
Nomadar Corp operates at the intersection of sports and technology, focusing on high-performance training programs and cultural exchange. The company aims to connect athletes, coaches, and fans through innovative technological solutions, enhancing sports development beyond physical borders. It offers services like the High Performance Training (HPT) program and promotes the legacy of iconic athletes.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.